New e-book provides global primer on antimicrobial stewardship
The British Society for Antimicrobial Chemotherapy (BSAC) today released a free e-book on global antimicrobial stewardship.
Antimicrobial Stewardship: From Principles to Practice, published in collaboration with the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the ESCMID Study Group for Antimicrobial Stewardship, provides an overview of antimicrobial resistance and the challenges it poses in healthcare settings around the world, a synopsis of antibiotic use and misuse, and examples of antimicrobial stewardship in various settings. In addition, it provides tools for setting up stewardship programs, resources to apply stewardship principles to a wide range of populations and clinical/care settings, and guidance on how to make the most of existing stewardship programs.
The multimedia e-book also contains links to case studies, videos, presentations, and other resources that illustrate good stewardship practices.
"We hope this book has something to offer everyone practicing in this area," editor-in-chief and BSAC President Dilip Nathwani, OBE, writes in the preface. "It aims to support health care professionals, or teams, or policy makers interested in learning about bringing the principles of stewardship to the bedside.
Mar 21 BSAC e-book (download link)
BARDA to tackle development of diagnostics, sepsis countermeasures
The US Biomedical Advanced Research and Development Authority (BARDA) is launching a new initiative to accelerate the development of innovative medical countermeasures against natural and man-made threats, with sepsis and pre-exposure, pre-symptomatic diagnostics as its initial targets.
In an email to colleagues, BARDA's Tyler Merkeley said the Division for Research, Innovation and Ventures (DRIVe) will "accelerate the research, development, and availability of transformative countermeasures to protect Americans from natural and international health security threats." Those threats include biological, chemical, radiological, and nuclear agents, as well as emerging infectious diseases
While sepsis and pre-exposure, pre-symptomatic diagnostics will be the initial targeted areas, the email said DRIVe will tackle additional challenges in coming years. DRIVe is looking to recruit staff over the next 60 days to support launch of the initiative.